FindTrial
Sign In

PredictIve value of metabonomics in left ventricular thrombosis after acute anterior myocardial infarction

PredictIve value of metabonomics in left ventricular thrombosis after acute anterior myocardial infarction

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023112
Enrollment
Unknown
Registered
2019-05-11
Start date
2019-05-11
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Gold Standard:The diagnostic performance of transthoracic echocardiography (TTE) was performed to detect left ventricular thrombus.
Index test:The&#32
metabonomics&#32
index&#32
of&#32
experimental&#32
group&#32
is&#32
different&#32
from&#32
that&#32
control&#32
and&#32
has&#32
statistical&#32
significance.

Sponsors

China-Japan Union Hospital of Jilin Unversity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with acute anterior myocardial infarction from January 2019 to January 2020 in China-Japan United Hospital of Jilin University.

Exclusion criteria

Exclusion criteria: Autoimmune disease patients.

Design outcomes

Primary

MeasureTime frame
Metabolomics product;Metabolomics product;—

Countries

China

Contacts

Public ContactWenqi Zhang

China-Japan Union Hospital of Jilin Unversity

zwq@163.com+86 13644407485

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026